Dosages for treatment with anti-ErbB2 antibodies | Patent Number 06627196

US 06627196 B1

Application Number9648067

Publication Number-

Pendency3 years, 1 month, 6 days

Filled DateAug 25, 2000

Priority DateAug 27, 1999

Publication Date-

Expiration DateAug 27, 2019

Inventor/ApplicantsSteven Shak
Sharon A. Baughman

ExaminesHOLLERAN, ANNE L

Art Unit1642

Technology Center1600

Assignments

Law Firm

You must be logged in to view

Attorneys

Subscription-Only

See the invalidated claims, subscribe to our Concierge Program.

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.